These data suggest that senescent tumor cells in CRC inhibit the intratumoral infiltration of CD8+ T cells through a high CXCL12 concentration induced loss of CXCR4 on CD8+ T cells that results in impaired directional migration. The gene discussed is CXCL12; the disease is neoplasm.